Upgrades/Downgrades
Updated: 13-Oct-26 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Enerflex | EFXT | CIBC | Neutral » Sector Outperform | ||
| Ollie's Bargain Outlet | OLLI | Gordon Haskett | Accumulate » Buy | $105 | |
| TIM S.A. | TIMB | BofA Securities | Underperform » Neutral | ||
| Telefonica Brasil | VIV | BofA Securities | Underperform » Neutral | ||
| Viking Holdings Ltd | VIK | Barclays | Equal Weight » Overweight | $102 | |
| V.F. Corp | VFC | Truist | Hold » Buy | $20 | |
| V.F. Corp | VFC | Piper Sandler | Neutral » Overweight | $20 | |
| Rexford Industrial Realty | REXR | Mizuho | Neutral » Outperform | $41 | |
| Prologis | PLD | Scotiabank | Sector Perform » Sector Outperform | $150 | |
| NatWest Group plc | NWG | Barclays | Equal Weight » Overweight | ||
| Gemini Space Station | GEMI | Citigroup | Sell » Neutral | $4.75 | |
| Galaxy Digital | GLXY | Citigroup | Neutral » Buy | $28 | |
| Exelon | EXC | KeyBanc Capital Markets | Underweight » Sector Weight | ||
| BCE Inc | BCE | Canaccord Genuity | Hold » Buy | ||
| American Electric | AEP | KeyBanc Capital Markets | Sector Weight » Overweight | $133 | |
| Spire Global | SPIR | Alliance Global Partners | Neutral » Buy | $15 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Contineum Therapeutics | CTNM | Robert W. Baird | Outperform » Neutral | $14 | |
| Securitize, Inc. | SECZ | Citigroup | Buy » Neutral | $14 | |
| RTX | RTX | Deutsche Bank | Buy » Hold | $208 | |
| Pershing Square, Inc. | PS | BofA Securities | Neutral » Underperform | $38 | |
| Lantheus Holdings | LNTH | Mizuho | Outperform » Neutral | $109 | |
| Foghorn Therapeutics | FHTX | Evercore ISI | Outperform » In-line | $3 | |
| Ero Copper | ERO | Scotiabank | Sector Outperform » Sector Perform | ||
| Chemours | CC | RBC Capital Mkts | Outperform » Sector Perform | $14 | |
| Cardinal Energy | CRLFF | RBC Capital Mkts | Outperform » Sector Perform | ||
| AT&T | T | Bernstein | Outperform » Mkt Perform | $24 | |
| AST SpaceMobile | ASTS | Piper Sandler | Overweight » Neutral | $54 | |
| Aritzia | ATZAF | Jefferies | Buy » Hold | ||
| Arch Capital | ACGL | Morgan Stanley | Overweight » Equal-Weight | $100 | |
| Allient | ALNT | JP Morgan | Overweight » Neutral | $120 | |
| Adobe | ADBE | HSBC Securities | Buy » Hold | $267 | |
| ACADIA Pharmaceuticals | ACAD | UBS | Buy » Neutral | $23 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| IRSA Inversiones | IRS | BofA Securities | Buy | $23.60 | |
| Orion180 Insurance Group | OIG | Deutsche Bank | Buy | $12.90 | |
| SmartRent | SMRT | B. Riley Securities | Buy | $1.75 | |
| YETI Holdings | YETI | Ladenburg Thalmann | Buy | $52 | |
| Wintrust Fin | WTFC | Deutsche Bank | Buy | $175 | |
| Westlake Corporation | WLK | Barclays | Underweight | $66 | |
| TechnipFMC | FTI | UBS | Buy | $89 | |
| Solstice Advance Materials | SOLS | Barclays | Overweight | $73 | |
| Sherwin-Williams | SHW | Barclays | Equal Weight | $348 | |
| RPM Inc | RPM | Barclays | Equal Weight | $107 | |
| Qnity Electronics | Q | Barclays | Overweight | $211 | |
| PPG Industries | PPG | Barclays | Overweight | $136 | |
| Orion180 Insurance Group | OIG | UBS | Buy | $14 | |
| Orion180 Insurance Group | OIG | RBC Capital Mkts | Outperform | $15 | |
| Orion180 Insurance Group | OIG | Raymond James | Mkt Perform | ||
| Orion180 Insurance Group | OIG | Goldman | Buy | $13 | |
| Orion180 Insurance Group | OIG | Citizens | Mkt Outperform | $20 | |
| Olin | OLN | Barclays | Equal Weight | $18 | |
| National Healthcare Properties | NHP | Raymond James | Outperform | $20 | |
| MSC Industrial | MSM | Barclays | Overweight | $152 | |
| MiniMed | MMED | Rothschild & Co Redburn | Buy | $30 | |
| LyondellBasell | LYB | Barclays | Equal Weight | $66 | |
| Linde plc | LIN | Barclays | Overweight | $577 | |
| Inhibikase Therapeutics | IKT | Chardan Capital Markets | Neutral | $1.50 | |
| Huntsman | HUN | Barclays | Equal Weight | $10 | |
| Gossamer Bio | GOSS | Chardan Capital Markets | Buy | $160 | |
| Escalade | ESCA | Ladenburg Thalmann | Neutral | ||
| Entegris | ENTG | Barclays | Overweight | $212 | |
| Element Solutions | ESI | Barclays | Overweight | $53 | |
| Electra Therapeutics | ETRA | TD Cowen | Buy | ||
| Electra Therapeutics | ETRA | Jefferies | Buy | $32 | |
| Electra Therapeutics | ETRA | Evercore ISI | Outperform | $36 | |
| Electra Therapeutics | ETRA | Cantor Fitzgerald | Overweight | ||
| Eastman Chemical | EMN | Barclays | Equal Weight | $72 | |
| DuPont | DD | Barclays | Overweight | $156 | |
| Dow | DOW | Barclays | Underweight | $30 | |
| Compass Diversified | CODI | Ladenburg Thalmann | Buy | $17 | |
| Chemours | CC | Barclays | Equal Weight | $16 | |
| Celanese | CE | Barclays | Equal Weight | $49 | |
| Axalta Coating Systems | AXTA | Barclays | Overweight | $45 | |
| Avient | AVNT | Barclays | Equal Weight | $44 | |
| Ascentage Pharma | AAPG | Citizens | Mkt Outperform | $35 | |
| American Outdoor Brands | AOUT | Ladenburg Thalmann | Buy | $22 | |
| American Healthcare REIT | AHR | Raymond James | Strong Buy | $62 | |
| Amer Sports | AS | Jefferies | Buy | $42 | |
| Albemarle | ALB | Barclays | Equal Weight | $109 | |
| Air Products | APD | Barclays | Overweight | $353 | |
| AIR Global | AIIR | Cantor Fitzgerald | Overweight | $11.03 | |
| Columbia Banking | COLB | Deutsche Bank | Hold | $32 | |
| Zapata Quantum | ZPTA | Chardan Capital Markets | Buy | $1 | |
| Kyntra Bio | KYNB | Maxim Group | Buy | $35 | |
| CoastalSouth Bancshares | COSO | Brean Capital | Buy | $33 | |
| Vail Resorts | MTN | Ladenburg Thalmann | Buy | $192 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Globant | GLOB | Wells Fargo | Equal Weight | $39 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |